She has raised over £40 million as principal or co-investigator and leads the Computational Cardiovascular Science team (www.cs.ox.ac.uk/ccs). She is interested in novel, interdisciplinary methodologies to accelerate therapy development, and replace animal testing through collaboration with industry and regulators. Her team has contributed pioneering case studies for the Digital Twin vision in precision medicine, and In Silico Trials for therapy testing. She has a deep commitment to training on technical aspects of modelling and simulation including verification, validation and uncertainty quantification, but importantly also skills for effective interdisciplinary and intersectoral collaborations. She regularly speaks in scientific conferences, to industry and public events.